Velindre Nhs Trust

This study tests whether adding an experimental drug (AZD5363) to standard hormone therapy (fulvestrant) can help control advanced breast cancer in postmenopausal women. About 150 women whose cancer worsened on previous hormone therapy will receive either the combo or a placebo. …